Literature DB >> 15080928

A model for identifying HERG K+ channel blockers.

Alex M Aronov1, Brian B Goldman.   

Abstract

Acquired long QT syndrome (LQTS) occurs frequently as a side effect of blockade of cardiac HERG K(+) channels by commonly used medications. A large number of structurally diverse compounds have been shown to inhibit K(+) current through HERG. There is considerable interest in developing in silico tools to filter out potential HERG blockers early in the drug discovery process. We describe a binary classification model that combines a 2D topological similarity filter with a 3D pharmacophore ensemble procedure to discriminate between HERG actives and inactives with an overall accuracy of 82%, with false negative and false positive rates of 29% and 15%, respectively. This model should be generally applicable in virtual library counterscreening against HERG.

Entities:  

Mesh:

Year:  2004        PMID: 15080928     DOI: 10.1016/j.bmc.2004.02.003

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  20 in total

1.  Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-à-go-go related gene potassium channels.

Authors:  Beiyan Zou; Haibo Yu; Joseph J Babcock; Pritam Chanda; Joel S Bader; Owen B McManus; Min Li
Journal:  Assay Drug Dev Technol       Date:  2010-12       Impact factor: 1.738

2.  Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening data.

Authors:  Claire L Gavaghan; Catrin Hasselgren Arnby; Niklas Blomberg; Gert Strandlund; Scott Boyer
Journal:  J Comput Aided Mol Des       Date:  2007-03-24       Impact factor: 3.686

3.  A QSAR toxicity study of a series of alkaloids with the lycoctonine skeleton.

Authors:  Malakhat A Turabekova; Bakhtiyor F Rasulev
Journal:  Molecules       Date:  2004-12-31       Impact factor: 4.411

4.  Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers.

Authors:  Khac-Minh Thai; Gerhard F Ecker
Journal:  Mol Divers       Date:  2009-02-14       Impact factor: 2.943

5.  Shape signatures: new descriptors for predicting cardiotoxicity in silico.

Authors:  Dmitriy S Chekmarev; Vladyslav Kholodovych; Konstantin V Balakin; Yan Ivanenkov; Sean Ekins; William J Welsh
Journal:  Chem Res Toxicol       Date:  2008-05-08       Impact factor: 3.739

6.  Cardio-vascular safety beyond hERG: in silico modelling of a guinea pig right atrium assay.

Authors:  Luca A Fenu; Ard Teisman; Stefan S De Buck; Vikash K Sinha; Ron A H J Gilissen; Marjoleen J M A Nijsen; Claire E Mackie; Wendy E Sanderson
Journal:  J Comput Aided Mol Des       Date:  2009-11-05       Impact factor: 3.686

7.  Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models.

Authors:  Yayu Tan; Yadong Chen; Qidong You; Haopeng Sun; Manhua Li
Journal:  J Mol Model       Date:  2011-06-10       Impact factor: 1.810

8.  Compilation and physicochemical classification analysis of a diverse hERG inhibition database.

Authors:  Remigijus Didziapetris; Kiril Lanevskij
Journal:  J Comput Aided Mol Des       Date:  2016-10-25       Impact factor: 3.686

9.  ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.

Authors:  Sichao Wang; Youyong Li; Junmei Wang; Lei Chen; Liling Zhang; Huidong Yu; Tingjun Hou
Journal:  Mol Pharm       Date:  2012-03-16       Impact factor: 4.939

10.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.